Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
49.90
-2.23 (-4.28%)
At close: May 9, 2025, 4:00 PM
50.00
+0.10 (0.20%)
After-hours: May 9, 2025, 7:43 PM EDT
Sanofi Revenue
Sanofi had revenue of 10.61B EUR in the quarter ending March 31, 2025, a decrease of -4.61%. This brings the company's revenue in the last twelve months to 45.17B, down -2.42% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.17B EUR
Revenue Growth
-2.42%
P/S Ratio
2.61
Revenue / Employee
544,970 EUR
Employees
82,878
Market Cap
127.51B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
SNY News
- 21 hours ago - Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label - Reuters
- 1 day ago - Pharma Worries Shift to Prices From Trade. Trump's Next Plan Could Sink Stocks. - Barrons
- 4 days ago - Sanofi: Investing in prevention builds Europe's health and competitiveness - GlobeNewsWire
- 10 days ago - Press Release: Annual General Meeting of April 30, 2025 - GlobeNewsWire
- 10 days ago - Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader - GlobeNewsWire
- 11 days ago - Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race - GlobeNewsWire
- 16 days ago - Sanofi (SNY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug - WSJ